상품명칭 |
5- [(2S) -2- 히드 록시 -2- (3,4,5- 트리메 톡시 페닐) 에틸] -2- 메 톡시 페놀 |
별명 |
; 5- [(2S) -2- 히드 록시 -2- (3,4,5- 트리메 톡시 페닐) 에틸] -2- 메 톡시 페놀; 벤제네에탄올, 3-하이드록시-4-메톡시-알파-(3,4,5-트리메톡시페닐)-, (알파S)-; 5- [(2R) -2- 히드 록시 -2- (3,4,5- 트리 메 톡시 페닐) 에틸] -2- 메 톡시 페놀;; (-)-콤브레타스타틴; (R)-3-하이드록시-4-메톡시-A-(3,4,5-트리메톡시페닐)벤제네탄올; 5- [(2R) -2- 하이드 록시 -2- (3,4,5- 트리메 톡시 페닐) 에틸] -2- 메 톡시 페놀; 벤제네에탄올, 3-하이드록시-4-메톡시-알파-(3,4,5-트리메톡시페닐)-, (R)-; 5- [2- 히드 록시 -2- (3,4,5- 트리메 톡시 페닐) 에틸] -2- 메 톡시 페놀;; 3-하이드록시-4-메톡시-알파-(3,4,5-트리메톡시페닐)벤제네에탄올; 벤제네에탄올, 3-하이드록시-4-메톡시-알파-(3,4,5-트리메톡시페닐)- |
영문 이름 |
5-[(2S)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; 5-[(2S)-2-Hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; benzeneethanol, 3-hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)-, (alphaS)-; 5-[(2R)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; ; (-)-Combretastatin; (R)-3-Hydroxy-4-methoxy-a-(3,4,5-trimethoxyphenyl)benzeneethanol; 5-[(2R)-2-Hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; Benzeneethanol, 3-hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)-, (R)-; 5-[2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; ; 3-Hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)benzeneethanol; benzeneethanol, 3-hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)- |
분자식 |
C18H22O6 |
분자량 |
334.3637 |
InChI |
InChI=1/C18H22O6/c1-21-15-6-5-11(8-14(15)20)7-13(19)12-9-16(22-2)18(24-4)17(10-12)23-3/h5-6,8-10,13,19-20H,7H2,1-4H3/t13-/m0/s1 |
cas번호 |
82855-09-2 |
분자 구조 |
|
밀도 |
1.213g/cm3 |
비등점 |
485.3°C at 760 mmHg |
굴절 지수 |
1.569 |
인화점 |
247.3°C |
증기압 |
3.14E-10mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|